259 related articles for article (PubMed ID: 24265293)
1. Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner.
Neradugomma NK; Subramaniam D; Tawfik OW; Goffin V; Kumar TR; Jensen RA; Anant S
Carcinogenesis; 2014 Apr; 35(4):795-806. PubMed ID: 24265293
[TBL] [Abstract][Full Text] [Related]
2. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
[TBL] [Abstract][Full Text] [Related]
3. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
[TBL] [Abstract][Full Text] [Related]
4. Impact of heat stress on prolactin-mediated ovarian JAK-STAT signaling in postpubertal gilts.
Roach CM; Bidne KL; Romoser MR; Ross JW; Baumgard LH; Keating AF
J Anim Sci; 2022 Jul; 100(7):. PubMed ID: 35772766
[TBL] [Abstract][Full Text] [Related]
5. The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance.
Park SY; Lee CJ; Choi JH; Kim JH; Kim JW; Kim JY; Nam JS
J Exp Clin Cancer Res; 2019 Sep; 38(1):399. PubMed ID: 31511084
[TBL] [Abstract][Full Text] [Related]
6. TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways.
Liu M; Inoue K; Leng T; Guo S; Xiong ZG
Cell Signal; 2014 Dec; 26(12):2773-81. PubMed ID: 25192910
[TBL] [Abstract][Full Text] [Related]
7. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
[TBL] [Abstract][Full Text] [Related]
8. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
9. The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.
Linher-Melville K; Singh G
BMC Cancer; 2014 Jun; 14():415. PubMed ID: 24913037
[TBL] [Abstract][Full Text] [Related]
10. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.
Sakamoto K; Triplett AA; Schuler LA; Wagner KU
Oncogene; 2010 Sep; 29(39):5359-69. PubMed ID: 20639901
[TBL] [Abstract][Full Text] [Related]
11. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin.
Jabbour HN; Critchley HO; Boddy SC
J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641
[TBL] [Abstract][Full Text] [Related]
12. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT
Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813
[TBL] [Abstract][Full Text] [Related]
13. Regulation of extracellular and intracellular prolactin on cell proliferation and survival rate through GHR/JAK2/STAT3 pathway in NSCLC.
Chou JC; Lieu FK; Ho DM; Shen HY; Lin PH; Hu S; Wang SW; Lin H; Wang PS
Chemosphere; 2021 Feb; 264(Pt 1):128604. PubMed ID: 33268090
[TBL] [Abstract][Full Text] [Related]
14. Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2.
Swaminathan G; Varghese B; Thangavel C; Carbone CJ; Plotnikov A; Kumar KG; Jablonski EM; Clevenger CV; Goffin V; Deng L; Frank SJ; Fuchs SY
J Endocrinol; 2008 Feb; 196(2):R1-7. PubMed ID: 18252943
[TBL] [Abstract][Full Text] [Related]
15. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
16. Anthraquinone derivative C10 inhibits proliferation and cell cycle progression in colon cancer cells via the Jak2/Stat3 signaling pathway.
Li Y; Guo F; Chen T; Zhang L; Qin Y
Toxicol Appl Pharmacol; 2021 May; 418():115481. PubMed ID: 33722666
[TBL] [Abstract][Full Text] [Related]
17. SRC family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells.
Piazza TM; Lu JC; Carver KC; Schuler LA
Mol Endocrinol; 2009 Feb; 23(2):202-12. PubMed ID: 19056863
[TBL] [Abstract][Full Text] [Related]
18. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling.
García-Martínez JM; Calcabrini A; González L; Martín-Forero E; Agulló-Ortuño MT; Simon V; Watkin H; Anderson SM; Roche S; Martín-Pérez J
Cell Signal; 2010 Mar; 22(3):415-26. PubMed ID: 19892015
[TBL] [Abstract][Full Text] [Related]
19. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways.
Wu W; Coss D; Lorenson MY; Kuo CB; Xu X; Walker AM
Biochemistry; 2003 Jun; 42(24):7561-70. PubMed ID: 12809512
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]